PP_1170x120_10-25-21

arformoterol tartrate inhalation solution

Glenmark receives ANDA approval for arformoterol tartrate inhalation solution

Glenmark receives ANDA approval for arformoterol tartrate inhalation solution

MUMBAI, India — Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (U.S. FDA) for arformoterol tartrate inhalation solution, 15 mcg/2 mL, Unit-Dose Vials, the generic version of Brovana Inhalation Solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals. Arformoterol tartrate inhalation solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in